Ceftriaxone Sodium

Description

Elimination: With a moderate elimination half-life of 5-9 hours in adults, once-daily dosing is feasible, enhancing patient compliance and treatment adherence.

Introducing PharmAlliance International Labs Private Limited’s Ceftriaxone Sodium Vial Range: Pioneering Antibiotic Therapy:

Welcome to PharmAlliance International Labs Private Limited, where innovation and excellence converge to redefine healthcare standards globally. Our Ceftriaxone Sodium Vial Range stands as a testament to our unwavering commitment to quality, efficacy, and patient-centric care, offering a potent antibiotic solution for a myriad of bacterial infections.

Understanding Ceftriaxone Sodium:

Ceftriaxone Sodium, a third-generation cephalosporin antibiotic, is renowned for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. This versatile antibiotic plays a pivotal role in combating a wide array of infectious diseases, offering a lifeline to patients battling bacterial infections worldwide.

Formulations and Strengths:

Our Ceftriaxone Sodium Vial Range is available in a variety of strengths to accommodate diverse patient needs and treatment protocols. From 250mg to 2000mg, our vials contain sterile powder for reconstitution, ensuring flexibility and convenience in dosing administration.

Indications and Therapeutic Applications:

Indicated for an extensive range of bacterial infections, including but not limited to:

• Lower respiratory tract infections such as pneumonia and bronchitis

• Urinary tract infections encompassing cystitis and pyelonephritis

• Skin and soft tissue infections, addressing conditions like cellulitis and wound infections

• Intra-abdominal infections, including peritonitis and cholecystitis

• Bone and joint infections, combating osteomyelitis effectively

• Meningitis, providing a crucial therapeutic intervention

• Gonorrhea and pelvic inflammatory disease (PID), offering a reliable treatment option

Pharmacokinetics Insights:

• Absorption: Administered parenterally, Ceftriaxone achieves rapid and extensive plasma concentrations post intramuscular or intravenous injection.

• Distribution: The drug exhibits widespread distribution into various bodily tissues and fluids, including but not limited to the lungs, kidneys, liver, and cerebrospinal fluid.

• • • Metabolism: Ceftriaxone undergoes minimal hepatic metabolism, with a significant proportion excreted unchanged in the urine, ensuring potent therapeutic activity.